These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: A 12-month double-blind assessment of betamethasone valerate aerosol in the management of asthma.
    Author: Vernon DR, Macleod JM, Kerr JW.
    Journal: Clin Allergy; 1976 May; 6(3):261-6. PubMed ID: 780001.
    Abstract:
    A double-blind trial of the topically active corticosteroid, betamethasone valerate in aerosol form, in the control of chronic asthma is reported. The results show that this is an extremely effective therapeutic agent in non-steroid dependent but nonetheless moderately severe asthmatics. Patients were well controlled on 800 mug of betamethasone valerate daily and control was maintained over a 12-month period. This form of treatment has few undersirable side effects but there is probably an increased incidence of oropharyngeal and laryngeal candidiasis. In particular, adrenocortical suppression was not noted.
    [Abstract] [Full Text] [Related] [New Search]